Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fesoterodine in Stress Urinary Incontinence
NCT01042236Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jan 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fesoterodine in stress urinary incontinence (SUI), sponsored by Pfizer. Started Jan 2009; status: completed.
02
Drugs
fesoterodine
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on NCT01042236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01042236.